Literature DB >> 16453002

Bax gene G(-248)A promoter polymorphism and chronic lymphocytic leukemia: lack of association with incidence, disease stage and progression-free survival.

H Nückel, U H Frey, L Sellmann, M Bau, J Dürig, U Dührsen, W Siffert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16453002     DOI： 10.1038/sj.leu.2404126

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  6 in total

1.  BAX and CDKN1A polymorphisms correlated with clinical outcomes of gastric cancer patients treated with postoperative chemotherapy.

Authors:  Xiaoting Wang; Youdong Lin; Fenghua Lan; Yinghao Yu; Xuenong Ouyang; Wei Liu; Feilai Xie; Xuzhou Wang; Qiaojia Huang
Journal:  Med Oncol       Date:  2014-09-30       Impact factor: 3.064

2.  The -938A/A genotype of BCL2 gene is associated with esophageal cancer.

Authors:  Zhigang Liu; Ruifang Sun; Weidong Lü; Chengxue Dang; Yangrong Song; Cheng Wang; Xi Zhang; Le Han; Hao Cheng; Wei Gao; Jia Liu; Guangyan Lei
Journal:  Med Oncol       Date:  2011-12-21       Impact factor: 3.064

3.  BAX -248 G>A and BCL2 -938 C>A Variant Lowers the Survival in Patients with Nasopharyngeal Carcinoma and Could be Associated with Tissue-Specific Malignancies: A Multi-Method Approach.

Authors:  Koustav Chatterjee; Saikat De; Sankar Deb Roy; Sushil Kumar Sahu; Arindom Chakraborty; Sandeep Ghatak; Nilanjana Das; Sudipa Mal; Nabanita Roy Chattopadhyay; Piyanki Das; R Rajendra Reddy; Syamantak Mukherjee; Ashok Kumar Das; Zoreng Puii; Eric Zomawia; Yengkhom Indibor Singh; Sam Tsering; Komri Riba; Shanmugam Rajasubramaniam; Amol Ratnakar Suryawanshi; Tathagata Choudhuri
Journal:  Asian Pac J Cancer Prev       Date:  2021-04-01

4.  Evaluation of Bax and Bak gene mutations and expression in breast cancer.

Authors:  Naglaa Mohamed Kholoussi; Sobhy E H El-Nabi; Nora Nassef Esmaiel; Naser Mohamed Abd El-Bary; Ahmed F El-Kased
Journal:  Biomed Res Int       Date:  2014-02-09       Impact factor: 3.411

Review 5.  Prognostic value and susceptibility of BAX rs4645878 polymorphism in cancer: A systematic review and meta-analysis.

Authors:  Ye Feng; Xianglei Chen; Yi Zheng; Qiao Liu; Haiwen Chen; Yuanhua Cai; Lixia Cao; Xiaolin Lai; Lili Pan; Yang Li; Shao-Yuan Wang
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Authors:  Sushil Kumar Sahu; Tathagata Choudhuri
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.